Max Planck Institute of Colloids and Interfaces, D-14424, Potsdam, Germany.
Nano Lett. 2011 May 11;11(5):2152-6. doi: 10.1021/nl200801n. Epub 2011 Apr 12.
Biocompatibility is of paramount importance for drug delivery, tumor labeling, and in vivo application of nanoscale bioprobes. Until now, biocompatible surface processing has typically relied on PEGylation and other surface coatings, which, however, cannot minimize clearance by macrophages or the renal system but may also increase the risk of chemical side effects. Cell membranes provide a generic and far more natural approach to the challenges of encapsulation and delivery in vivo. Here we harness for the first time living cells as "factories" to manufacture cell membrane capsules for encapsulation and delivery of drugs, nanoparticles, and other biolabels. Furthermore, we demonstrate that the built-in protein channels of the new capsules can be utilized for controlled release of encapsulated reagents.
生物相容性对于药物输送、肿瘤标记和纳米级生物探针的体内应用至关重要。到目前为止,生物相容性表面处理通常依赖于聚乙二醇化和其他表面涂层,然而,这些方法不能最大限度地减少巨噬细胞或肾脏系统的清除,但也可能增加化学副作用的风险。细胞膜为封装和体内递药提供了一种通用且更自然的方法。在这里,我们首次利用活细胞作为“工厂”,制造细胞膜胶囊,用于封装和递药、纳米颗粒和其他生物标记物。此外,我们还证明了新胶囊内置的蛋白质通道可用于控制封装试剂的释放。